SAVA
Cassava Sciences Inc
Clinical-stage biotechnology company developing drugs for neurodegenerative diseases
CUSIP: 14817C107HealthcareUS1 holder
Total Value
$1.77M
Total Shares
40.6K
Net Share Change
+40.6K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Greenlight Capital
$1.77M40.6K sharesNEW